Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
UPB is expected to report earnings to rise 18.67% to -88 cents per share on August 12
Q2'26
Est.
$-0.89
Q1'26
Beat
by $0.10
Q4'25
Beat
by $0.06
The last earnings report on May 13 showed earnings per share of -75 cents, beating the estimate of -85 cents. With 261.45K shares outstanding, the current market capitalization sits at 342.85M.